„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary

„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary

Piracetam has been available on the market since 1971. Its primary indication is the age-related memory decline. The objective of this review is to highlight the controversies surrounding in the use of piracetam. Piracetam modulates membrane fluidity, which is decreased in the elderly, and this exp...

Full description

Bibliographic Details
Main Authors: András Érszegi, Máté Vámos, Réka Viola, Dezső Csupor, Anna Vágvölgyi
Format: Article
Language:English
Published: Promenade Kft 2024-04-01
Series:Cardiologia Hungarica
Subjects:
piracetam
nootropic
memory decline
cognitive dysfunction
dementia
Online Access:https://cardiologia.hungarica.eu/current-issue/cognitive-enhancement-or-non-evidence-based-nootropic-abuse-use-of-piracetam-in-hungary

Internet

https://cardiologia.hungarica.eu/current-issue/cognitive-enhancement-or-non-evidence-based-nootropic-abuse-use-of-piracetam-in-hungary

Similar Items